Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-27

Clinical Trial Update: Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode Psychosis [Phase 3]

View source ↗

Summary

A completed Phase 3 dose-finding trial compared 200 mg vs 400 mg daily doses of quetiapine fumarate in first-episode psychosis to determine the optimal dosing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Psychosis | Phase 3 | Status: COMPLETED